Hang Yang

960 total citations
51 papers, 624 citations indexed

About

Hang Yang is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Hang Yang has authored 51 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 20 papers in Pathology and Forensic Medicine and 12 papers in Molecular Biology. Recurrent topics in Hang Yang's work include Lymphoma Diagnosis and Treatment (20 papers), CNS Lymphoma Diagnosis and Treatment (8 papers) and Viral-associated cancers and disorders (6 papers). Hang Yang is often cited by papers focused on Lymphoma Diagnosis and Treatment (20 papers), CNS Lymphoma Diagnosis and Treatment (8 papers) and Viral-associated cancers and disorders (6 papers). Hang Yang collaborates with scholars based in China, United States and Singapore. Hang Yang's co-authors include Peng Sun, Cui Chen, Xiwen Bi, Yi Xia, Wenqi Jiang, Panpan Liu, Xin An, Feng‐Hua Wang, Fei Zhang and Zhiming Li and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Oncogene.

In The Last Decade

Hang Yang

43 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hang Yang China 13 309 184 158 156 89 51 624
Sally Baron‐Hay Australia 14 388 1.3× 237 1.3× 113 0.7× 122 0.8× 70 0.8× 48 775
Akihiro Ohmoto Japan 14 418 1.4× 158 0.9× 130 0.8× 114 0.7× 99 1.1× 75 706
Satoshi Okazaki Japan 17 391 1.3× 169 0.9× 130 0.8× 102 0.7× 153 1.7× 86 725
Florian Huemer Austria 13 323 1.0× 114 0.6× 76 0.5× 79 0.5× 133 1.5× 46 502
Miaoxia He China 16 311 1.0× 311 1.7× 173 1.1× 299 1.9× 67 0.8× 52 800
Lobna Ayadi Tunisia 14 191 0.6× 147 0.8× 126 0.8× 139 0.9× 134 1.5× 87 613
Alexis D. Leal United States 15 545 1.8× 244 1.3× 127 0.8× 188 1.2× 128 1.4× 57 888
Inna M. Chen Denmark 16 583 1.9× 171 0.9× 152 1.0× 51 0.3× 148 1.7× 53 839
Zdeněk Adam Czechia 14 298 1.0× 482 2.6× 134 0.8× 95 0.6× 59 0.7× 156 929
Bogdan Fetică Romania 10 151 0.5× 119 0.6× 81 0.5× 78 0.5× 50 0.6× 58 441

Countries citing papers authored by Hang Yang

Since Specialization
Citations

This map shows the geographic impact of Hang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hang Yang more than expected).

Fields of papers citing papers by Hang Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hang Yang. The network helps show where Hang Yang may publish in the future.

Co-authorship network of co-authors of Hang Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Hang Yang. A scholar is included among the top collaborators of Hang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hang Yang. Hang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Jun, et al.. (2025). Congenital intestinal malrotation, duodenal obstruction combined with dextrocardia: a rare case report. Frontiers in Pediatrics. 13. 1554891–1554891.
2.
Sun, Peng, et al.. (2023). Tislelizumab monotherapy in patients with previously untreated early-stage classical Hodgkin lymphoma: a real-world study. Annals of Hematology. 103(3). 793–801. 1 indexed citations
3.
Zhu, Yanan, Jing Li, Hang Yang, et al.. (2023). The potential role of m6A reader YTHDF1 as diagnostic biomarker and the signaling pathways in tumorigenesis and metastasis in pan-cancer. Cell Death Discovery. 9(1). 34–34. 26 indexed citations
5.
Yang, Hang, Chen Yang, Liyun Zheng, et al.. (2023). The E3 ubiquitin ligase TRIM17 promotes gastric cancer survival and progression via controlling BAX stability and antagonizing apoptosis. Cell Death and Differentiation. 30(10). 2322–2335. 21 indexed citations
6.
Li, Li, Yan Ma, Xiaobo Wang, et al.. (2023). Efficacy and Safety of Selinexor-Based Combination Therapy in CNS Lymphoma: A Retrospective Experience. Blood. 142(Supplement 1). 6301–6301.
7.
Yang, Chen, Liyun Zheng, Xiaoli Zhao, et al.. (2023). FBXO28 suppresses liver cancer invasion and metastasis by promoting PKA-dependent SNAI2 degradation. Oncogene. 42(39). 2878–2891. 8 indexed citations
8.
Yang, Hang, et al.. (2023). UPS: Opportunities and challenges for gastric cancer treatment. Frontiers in Oncology. 13. 1140452–1140452. 5 indexed citations
9.
Sun, Peng, Yu Wang, Hang Yang, et al.. (2022). Combination of Anti-PD-1 Antibody, Anlotinib and Pegaspargase “Sandwich” With Radiotherapy in Localized Natural Killer/T Cell Lymphoma. Frontiers in Immunology. 13. 766200–766200. 10 indexed citations
11.
Liu, Bingyao, Linlin Zhang, Hang Yang, et al.. (2022). SIK2 protects against renal tubular injury and the progression of diabetic kidney disease. Translational research. 253. 16–30. 11 indexed citations
12.
Han, Lei, Yan Liu, Lijuan Ye, et al.. (2021). MicroRNA-106a regulates autophagy-related cell death and EMT by targeting TP53INP1 in lung cancer with bone metastasis. Cell Death and Disease. 12(11). 1037–1037. 31 indexed citations
13.
Sun, Peng, Yu Wang, Cui Chen, et al.. (2021). R-split-EPOCH plus high dose methotrexate in untreated diffuse large B cell lymphoma with MYC rearrangement or double expression of MYC and BCL-2. Journal of Cancer. 12(7). 2059–2064. 1 indexed citations
14.
Wang, Jianwei, Xuanye Zhang, Hang Yang, et al.. (2020). Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis. Frontiers in Oncology. 10. 588314–588314. 9 indexed citations
15.
Liu, Panpan, Kefeng Wang, Jietian Jin, et al.. (2018). Role of radiation therapy in primary breast diffuse large B‐cell lymphoma in the Rituximab era: a SEER database analysis. Cancer Medicine. 7(5). 1845–1851. 12 indexed citations
17.
Sun, Peng, Fei Zhang, Chao Ren, et al.. (2016). Prognostic impact of body mass index stratified by smoking status in patients with esophageal squamous cell carcinoma. OncoTargets and Therapy. Volume 9. 6389–6397. 9 indexed citations
18.
Yang, Hang, Qing Xia, Yong Zou, et al.. (2015). M410, a combretastatin A4 analogue, disrupts microtubules and inhibits HIF-1α in human breast cancer cells. Oncology Reports. 34(1). 334–340. 5 indexed citations
19.
Yang, Hang, et al.. (2015). Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal cancer cells. International Journal of Molecular Medicine. 36(6). 1556–1562. 23 indexed citations
20.
Yang, Hang, Ye Cao, Ming Song, et al.. (2015). The prognostic value of Tiam1 protein expression in head and neck squamous cell carcinoma: a retrospective study. Chinese Journal of Cancer. 34(3). 614–21. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026